Sun Pharmaceutical Industries Limited has informed the Exchange about Completion and Result of Postal Ballot dated 07 April 2026
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharmaceutical conducted a postal ballot with e-voting from 09 April to 08 May 2026. Shareholders approved the appointment of Ms. Satyavavati Berera as an Independent Director for a term of five years, effective 08 May 2026. The resolution received the required shareholder majority. The voting results and Scrutinizer's Report have been submitted to the stock exchanges and are available on the company's website.
The appointment of an independent director strengthens board governance and compliance with SEBI listing requirements. This is a routine governance update that should be neutral for the stock, as independent director appointments are standard practice for listed companies.